The ASX has been up 1% higher at 7,721 points.
Invictus Energy (ASX:IVZ) has been among the most watched on HotCopper forums after the company confirmed Musuma-1 as the first high-impact exploration well to be drilled outside the Mukuyu gas-condensate discovery area, targeting a new play type in the Cabora Bassa Basin.
Invictus Energy has been 5.5 cents.
Neuren Pharmaceuticals (ASX:NEU) has also been trending on news the primary endpoints for its Phase 3 pivotal clinical trial of its drug in Phelan-McDermid syndrome have been confirmed in a meeting with the U.S. FDA.
Neuren has been $10.74.
And, finally, Bellevue Gold (ASX:BGL) has revised its full-year production guidance down and scrapped its five-year growth plan after “uncharacteristic geological factors” hindered the gold miner’s output in the March quarter.
The company will also soon be running a $156.5 million placement to provide working capital for a revised mine plan and de-risk its balance sheet.
Bellevue Gold was $1.145 before its trading suspension.
More market news
Kowtow: “Biggest day in financial history” on Trump’s tariffs retreat
Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst
Join the discussion: See what’s trending right now on HotCopper, Australia’s largest stock forum, and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。